
Opinion|Videos|January 13, 2025
Looking Ahead: Ph+ ALL in 2025 and Beyond
Dr. Bijal Shah offers forward-looking perspectives on the future of Ph+ ALL treatment, highlighting potential advancements, emerging challenges, and opportunities for improving patient care in 2025 and beyond.
Advertisement
- Closing thoughts
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
US Employer Health Care Costs Projected to Rise 9.5% in 2027
2
Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug
3
FDA Clears First Single-Biomarker Blood Test for Alzheimer
4
New York Experts Push for Coordinated Obesity Care Teams
5




